{
    "sourceOrganization": [
        {
            "@type": "ResearchProject",
            "name": "NIAID HLA RGIMDC Program",
            "abstract": "The HLA (human leukocyte antigen) Region Genetics in Immune-Mediated Diseases Consortium (HLA RGIMDC) studies how genetic variations in the HLA gene region and killer immunoglobulin-like receptor gene family influence immune-mediated diseases. The consortium aims to improve understanding of disease mechanisms and potential therapeutic targets.",
            "description": "This purpose of HLA (human leukocyte antigen) Region Genetics in Immune-Mediated Diseases Consortium (HLA RGIMDC) is to understand how the HLA gene region and killer immunoglobulin-like receptor gene family are associated with immune-mediated diseases. For more information, visit the NIAID program page: https://www.niaid.nih.gov/research/hla-region-genetics-immune-mediated-diseases-consortium",
            "alternateName": [
                "HLA Region Genetics in Immune-Mediated Diseases Consortium"
            ],
            "url": "https://www.niaid.nih.gov/research/hla-region-genetics-immune-mediated-diseases-consortium",
            "parentOrganization": [
                "NIAID"
            ]
        }
    ]
}